Circulating Tumor DNA Identifies EGFR Coamplification as a Mechanism of Resistance to Crizotinib in a Patient with Advanced MET-Amplified Lung Adenocarcinoma

Circulating Tumor DNA Identifies EGFR Coamplification as a Mechanism of Resistance to Crizotinib in a Patient with Advanced MET-Amplified Lung Adenocarcinoma

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of Thoracic Oncology - Volume 12, Issue 10, October 2017, Pages e155-e157

Ibiayi MD, David PhD, Jochen MD, PhD, Alexa B. PhD, Lauren MS, Mari MD, Subba R. MD, Rebecca S. MD, MPH, Siraj M. MD, PhD, Vincent A. MD, Alice T. MD, PhD,